Sudarshan Pharma Industries Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | 
|---|---|---|---|
| Revenue | 169.10 | 143.73 | 162.48 | 
| Operating Expense | 157.40 | 132.03 | 148.01 | 
| Net Profit | 4.40 | 3.73 | 7.03 | 
| Net Profit Margin | 2.60 | 2.60 | 4.33 | 
| Earning Per Share | 0.18 | 0.15 | 0.29 | 
| EBIDTA | 12.45 | 11.40 | 14.77 | 
| Effective Tax Rate | 10 | 10 | 17.55 | 
| Particulars | Sep 2025 | 
|---|---|
| Revenue | 169.10 | 
| Operating Expense | 157.40 | 
| Net Profit | 4.40 | 
| Net Profit Margin | 2.60 | 
| Earning Per Share | 0.18 | 
| EBIDTA | 12.45 | 
| Effective Tax Rate | 10.00 | 
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | 
|---|---|---|---|
| Total Revenue Annual | 502.51 | 465.56 | 461.33 | 
| Operating Expenses Annual | 464.00 | 442.96 | 446.64 | 
| Operating Profit Annual | 38.56 | 25.36 | 15.81 | 
| Interest Annual | 15.96 | 9.03 | 5.40 | 
| Depreciation | 1.31 | 1.23 | 0.91 | 
| Net Profit Annual | 15.88 | 11.36 | 7.04 | 
| Tax Annual | 5.41 | 3.74 | 2.46 | 
| Particulars | Mar 2025 | 
|---|---|
| Total Revenue Annual | 502.51 | 
| Operating Expenses Annual | 464.00 | 
| Operating Profit Annual | 38.56 | 
| Interest Annual | 15.96 | 
| Depreciation | 1.31 | 
| Net Profit Annual | 15.88 | 
| Tax Annual | 5.41 | 
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | 
|---|---|---|---|
| Cash Flow at the Beginning | 0.13 | 11.71 | 0.23 | 
| Cash Flow from Operations | 34.91 | 9.69 | -28.79 | 
| Cash Flow from Investing | -20.24 | -9.08 | -25.65 | 
| Cash Flow from Financing | -14.41 | -12.18 | 65.93 | 
| Cash Flow at the End | 0.39 | 0.13 | 11.71 | 
| Particulars | Mar 2025 | 
|---|---|
| Cash Flow at the Beginning | 0.13 | 
| Cash Flow from Operations | 34.91 | 
| Cash Flow from Investing | -20.24 | 
| Cash Flow from Financing | -14.41 | 
| Cash Flow at the End | 0.39 | 
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | 
|---|---|---|---|
| PBDIT Margin (%) | 8.23 | 5.45 | 3.43 | 
| PBIT Margin (%) | 7.97 | 5.18 | 3.23 | 
| PBT Margin (%) | 7.47 | 4.61 | 2.63 | 
| Net PROFIT Margin (%) | 3.16 | 2.44 | 1.53 | 
| Return On Networth / Equity (%) | 14.79 | 10.69 | 10.77 | 
| Return On Networth /Employed (%) | 15.30 | 13.63 | 15.24 | 
| Return On Assets (%) | 6.07 | 6.42 | 7.20 | 
| Total Debt / Equity (X) | 1.15 | 0.66 | 0.49 | 
| Asset Turnover Ratio (%) | 1.92 | 2.63 | 4.72 | 
| Particulars | Mar 2025 | 
|---|---|
| PBDIT Margin (%) | 8.23 | 
| PBIT Margin (%) | 7.97 | 
| PBT Margin (%) | 7.47 | 
| Net PROFIT Margin (%) | 3.16 | 
| Return On Networth / Equity (%) | 14.79 | 
| Return On Networth /Employed (%) | 15.30 | 
| Return On Assets (%) | 6.07 | 
| Total Debt / Equity (X) | 1.15 | 
| Asset Turnover Ratio (%) | 1.92 | 
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | 
|---|---|---|---|
| Fixed Assets Annual | 19.79 | 20.57 | 19.89 | 
| Total Current Assets Annual | 333.83 | 240.85 | 198.51 | 
| Non Current Assets Annual | 66.57 | 43.99 | 33.96 | 
| Total Shareholders Funds Annual | 131.31 | 111.62 | 100.98 | 
| Total Assets Annual | 400.40 | 284.84 | 232.47 | 
| Particulars | Mar 2025 | 
|---|---|
| Fixed Assets Annual | 19.79 | 
| Total Current Assets Annual | 333.83 | 
| Non Current Assets Annual | 66.57 | 
| Total Shareholders Funds Annual | 131.31 | 
| Total Assets Annual | 400.40 | 
EPS (INR)
Expected
0.17
Reported
0.16
Surprise
-5.88%
Jun 2025
EPS beaten by -5.88%
Mar 2025
EPS beaten by -5.88%
Dec 2024
EPS beaten by 0.00%
